$INFI: Infinity Reports Clinical and Translational Data from Expansion …

Date: Saturday, November 10th, 2018

Stock(s) mentioned:

Source: Benzinga (https://www.benzinga.com)

Summary: 10, 2018 /PRNewswire/ — Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) announced that data to be presented today at the 33 Annual Meeting of the Society for …

Full article address: https://www.benzinga.com/pressreleases/18/11/r12675502/infinity-reports-clinical-and-translational-data-from-expansion-cohort

Related News:

$INFI: Infinity Pharmaceuticals’ (INFI) CEO Adelene Perkins on Q3 2018 …

$BMY $INFI: Infinity Pharma teams up with Bristol-Myers Squibb in urothelial cancer

$BMY $INFI: Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New …

$INFI: Infinity Pharma up 7% premarket on $22M milestone from Verastem

Latest News:

$FB $AMZN $VILLX $WTW $TWOU $STE: Smaller Cap Stocks Could Make Great Stocking Stuffers Ahead of 2019

$PFE: Pfizer declares $0.36 dividend

$DFS: Forge First Asset Management November 2018 Commentary: Short …

$D: Dominion Energy Completes Previously Announced Asset Sales

$APRI: Apricus Biosciences Adjourns Special Meeting of Stockholders to …

$LMT: Lockheed wins US Army work to supply equipment for combat training

$TGP.PA: Teekay LNG Partners LP Cum Red Pfd Partnership Units Series A …

$TGP.PB: Teekay LNG Partners LP Cum Red Perp Pfd Registered Shs Series …

$ALQA $BEL $CIVI $XPO: Midday Gainers / Losers

$ACOR $KELYA $HIFR: Is Acorda Therapeutics Inc (ACOR) A Good Stock To Buy?

$IQIN: IndexIQ Brings A New Look To International Equities